LDB2 (LIM domain binding 2) is a transcriptional coregulator that binds to LIM domains of transcription factors to modulate gene expression across multiple biological contexts 1. In development, LDB2 exhibits functional redundancy with LDB1, playing stage-dependent roles in retinal progenitor cell maintenance and photoreceptor generation through regulation of Vsx2, Rax, and signaling pathways 2. During corticospinal motor neuron differentiation, LDB2 cooperates with LDB1 to control layer 5 pyramidal neuron specification, with compensatory functions between the two proteins 3. In vascular biology, LDB2 regulates DLL4 expression in endothelial cells by forming oligomeric complexes at promoter regions, influencing angiogenic sprouting 4. Clinically, LDB2 functions as a tumor suppressor across multiple cancer types. In bladder cancer, LDB2 is downregulated in metastatic tissues and activates p38 MAPK/ERK1/2/JNK signaling to inhibit proliferation, invasion, and metastasis, with diagnostic AUC of 0.91-0.96 1. Similarly, in lung adenocarcinoma, decreased LDB2 expression correlates with poor prognosis, and overexpression inhibits cell proliferation through cell cycle arrest 5. In colorectal cancer screening, LDB2 methylation serves as a noninvasive biomarker for early detection of advanced adenomas and cancer 6. Neuropsychiatrically, LDB2 cooperates with EGR transcription factors to regulate Arc expression in the amygdala; dysregulation of this LDB2-EGR axis contributes to schizophrenia pathogenesis 7.